NUTEX HEALTH INC. Financials Nutex Health Inc. OTC Markets
Equities
NUTX
US67079U1088
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6616 USD | +1.33% |
|
-5.21% | -89.66% |
| Apr. 22 | Nutex Health Inc. Announces Changes to Its Board of Directors | CI |
| Apr. 12 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 1,237 | 120.7 | 32.88 | - |
| Enterprise Value (EV) 1 | 1,237 | 120.7 | 32.88 | 32.88 |
| P/E ratio | -2.84 x | -2.57 x | -2.21 x | -4.41 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 5.64 x | 0.49 x | 0.12 x | 0.1 x |
| EV / Revenue | 5.64 x | 0.49 x | 0.12 x | 0.1 x |
| EV / EBITDA | 98.6 x | 11.2 x | 1.59 x | 1.03 x |
| EV / FCF | 34,389,180 x | - | - | - |
| FCF Yield | 0% | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 43,408 | 44,719 | 49,695 | - |
| Reference price 2 | 28.50 | 2.700 | 0.6616 | 0.6616 |
| Announcement Date | 3/2/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 330.1 | 219.3 | 247.6 | 283.6 | 330 |
| EBITDA 1 | - | 12.55 | 10.83 | 20.7 | 31.8 |
| EBIT 1 | - | -4.578 | -1.292 | 9 | 13.8 |
| Operating Margin | - | -2.09% | -0.52% | 3.17% | 4.18% |
| Earnings before Tax (EBT) 1 | - | -419.6 | -48.49 | -5.5 | -0.2 |
| Net income 1 | 132.6 | -424.8 | -45.79 | -11.1 | -7.2 |
| Net margin | 40.17% | -193.7% | -18.49% | -3.91% | -2.18% |
| EPS 2 | - | -10.05 | -1.050 | -0.3000 | -0.1500 |
| Free Cash Flow | - | 35.97 | - | - | - |
| FCF margin | - | 16.4% | - | - | - |
| FCF Conversion (EBITDA) | - | 286.7% | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 6/16/22 | 3/2/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 53.72 | 56.33 | 58.92 | 62.72 | 69.67 | 64.8 | 66.7 | 71.7 | 80.4 | 77.8 |
| EBITDA 1 | - | -5.908 | 2.438 | 3.995 | 1.279 | 3.116 | 4 | 5.5 | 4.2 | 7.1 | 6.6 |
| EBIT 1 | - | -5.779 | -4.228 | -0.3625 | -0.8212 | 4.077 | 0.7 | 2.2 | 1.4 | 4.8 | 2.1 |
| Operating Margin | - | -10.76% | -7.51% | -0.62% | -1.31% | 5.85% | 1.08% | 3.3% | 1.95% | 5.97% | 2.7% |
| Earnings before Tax (EBT) 1 | - | 1.478 | -7.833 | -5.082 | -4.866 | -30.71 | -3.3 | -1.3 | -2.1 | 1.3 | -1.4 |
| Net income 1 | -422.5 | -4.421 | -5.147 | -3.479 | -5.542 | -31.62 | -3.5 | -2 | -3.6 | -2.1 | -2.3 |
| Net margin | - | -8.23% | -9.14% | -5.9% | -8.84% | -45.38% | -5.4% | -3% | -5.02% | -2.61% | -2.96% |
| EPS 2 | -9.750 | - | -0.1500 | -0.1500 | -0.1500 | -0.7500 | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/22/22 | 3/2/23 | 5/15/23 | 8/9/23 | 11/9/23 | 3/28/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | 36 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 6/16/22 | 3/2/23 | 3/28/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6616
USD
Average target price
6
USD
Spread / Average Target
+806.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B |
- Stock Market
- Equities
- NUTX Stock
- NUTX Stock
- Financials Nutex Health Inc.
